about 1 year ago Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease Relapse Read More
about 1 year ago A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination gen Read More
about 1 year ago Reply to Di Cosimo et al.: Advancing circulating tumor DNA for recurrent breast cancer Read More
about 1 year ago Treatment response monitoring using a tumor-informed circulating tumor DNA test in an advanced triple negative breast cancer patient: A case Read More
about 3 years ago Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk Magbanua et al. 2021 NPJ Breast Cancer Read More
over 3 years ago Circulating tumor DNA in neoadjuvant treated breast cancer reflects response and survival Magbanua et al. 2020 Annals of Oncology Read More
about 5 years ago Personalized detection of circulating tumor DNA antedates breast cancer metastatic recurrence Coombes et al. 2019 Clin. Cancer Res. Read More
almost 5 years ago Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients Wi Christensen et al. 2019 J. Clin. Oncol. Read More
almost 3 years ago ctDNA guiding adjuvant immunotherapy in urothelial carcinoma Powles T, Assaf ZA, Davarpanah N, et al. Nature. Read More
about 2 years ago Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder Szabados B, Kockx M, Assaf ZA, et al. European Urology. Read More
over 1 year ago Molecular Residual Disease and Efficacy of Adjuvant Chemotherapy in Patients with Colorectal Cancer Read More
over 1 year ago Circulating tumor DNA (ctDNA) serial analysis during progression on PD-1 blockade and later CTLA-4 rescue in patients with mismatch repair d Read More
over 1 year ago DENEB: Development of new criteria for curability after local excision of pathological T1 colorectal cancer using liquid biopsy Read More
about 1 year ago Early detection of circulating tumor DNA post-operatively enables discovery of resectable metastatic disease in a patient with colon cancer Read More
over 1 year ago Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Effic Read More
about 1 year ago A multicenter, prospective observational study to evaluate the impact of circulating tumor DNA guided therapy on patients with colorectal ca Read More
almost 3 years ago Detection of molecular residual disease using personalized circulating tumor DNA assay in colorectal cancer patients undergoing resection of Loupakis et al. 2021 JCO-PO Read More
almost 3 years ago ctDNA Clearance and Radiographic Resolution of Disease in Response to Dual Checkpoint Inhibition in metastatic microsatellite stable colo... Schneider et al. 2021 Case reports in Onc. Read More